Edgar Ben-Josef, M.D.
Edgar Ben-Josef, M.D.
Professor of Radiation Oncology at the Hospital of the University of Pennsylvania
Department: Radiation Oncology
Contact information
Department of Radiation Oncology
University of Pennsylvania
Perelman Center for Advanced Medicine
2 West
3400 Civic Center Blvd.
Philadelphia, PA 19104
University of Pennsylvania
Perelman Center for Advanced Medicine
2 West
3400 Civic Center Blvd.
Philadelphia, PA 19104
Office: 215-662-3932
Education:
B.Med.Sc.
The Hebrew University-Hadassah School of Medicine, Jerusalem, Israel, 1980.
M.D.
The Hebrew University-Hadassah School of Medicine, 1983.
Permanent linkB.Med.Sc.
The Hebrew University-Hadassah School of Medicine, Jerusalem, Israel, 1980.
M.D.
The Hebrew University-Hadassah School of Medicine, 1983.
Selected Publications
Theodore S. Hong, MD, Walter Bosch, PhD, Sunil Krishnan, MD, PhD, Tae Kim, MD, Harvey Mamon, MD, PhD, Paul Shyn, MD, Edgar Ben-Josef, MD, Jinsil Seong, MD, Michael Haddock, MD, Jason Cheng, MD, Mary Feng, MD, Kevin Stephans, MD, David Roberge, MD, Christopher Crane, MD, and Laura A. Dawson, MD: Interobserver variability in target definition for hepatocellular carcinoma (HCC) with and without portal vein thrombus: Radiation Therapy Oncology Group (RTOG) consensus guidelines. ASTRO 2013 2013.John Plastaras, Abigail Berman, Smith Apisarnthanarax, Stefan Both, Kristi Varillo, Gary L. Larson, Edgar Ben-Josef, James M. Metz: Proton reirradiation of locally recurrent pancreatic and ampullary adenocarcinomas. Gastrointestinal Cancers Symposium 2013.
Mary Feng, MD; Matthew J. Schipper, PhD; James M. Balter, PhD; Martha M. Matuszak, PhD; Scott W. Hadley, PhD; Theodore H. Welling, MD; Michael L. Volk, MD; Charlie Pan, MD; Edgar Ben-Josef, MD; Theodore S. Lawrence, MD, PhD.: A Phase II Trial of Individualized Adaptive Stereotactic Body Radiotherapy (SBRT) for Patients at High Risk for Liver Damage. ASTRO 2013 2013.
A. Fernandes, B. K. Teo, L. Yin, M. Rosen, J. P. Plastaras, E. Ben-Josef, J. M. Metz, S. Apisarnthanarax: Comparative Assessment of Liver Tumor Motion Using CineMRI versus 4DCT. ASTRO 55th Annual Meeting 2013.
Deville Curtiland, Ben-Josef Edgar, Vapiwala Neha: Radiation therapy modalities for prostate cancer. JAMA : the journal of the American Medical Association 308(5): 451; author reply 451-2, Aug 2012.
Feng Mary, Smith David E, Normolle Daniel P, Knol James A, Pan Charlie C, Ben-Josef Edgar, Lu Zheng, Feng Meihua R, Chen Jun, Ensminger William, Lawrence Theodore S: A Phase I Clinical and Pharmacology Study Using Amifostine as a Radioprotector in Dose-escalated Whole Liver Radiation Therapy. Int J Radiat Oncol Biol Phys 83(5): 1441-7, Aug 2012.
Goodman Karyn A, Regine William F, Dawson Laura A, Ben-Josef Edgar, Haustermans Karin, Bosch Walter R, Turian Julius, Abrams Ross A: Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer. Int J Radiat Oncol Biol Phys 83(3): 901-8, Jul 2012.
Hunter Klaudia U, Feng Felix Y, Griffith Kent A, Francis Isaac R, Lawrence Theodore S, Desai Sameer, Murphy James D, Zalupski Mark M, Ben-Josef Edgar: Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 83(3): 921-6, Jul 2012.
Tempero Margaret A, Arnoletti J Pablo, Behrman Stephen W, Ben-Josef Edgar, Benson Al B, Casper Ephraim S, Cohen Steven J, Czito Brian, Ellenhorn Joshua D I, Hawkins William G, Herman Joseph, Hoffman John P, Ko Andrew, Komanduri Srinadh, Koong Albert, Ma Wen Wee, Malafa Mokenge P, Merchant Nipun B, Mulvihill Sean J, Muscarella Peter, Nakakura Eric K, Obando Jorge, Pitman Martha B, Sasson Aaron R, Tally Anitra, Thayer Sarah P, Whiting Samuel, Wolff Robert A, Wolpin Brian M, Freedman-Cass Deborah A, Shead Dorothy A: Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network 10(6): 703-13, Jun 2012.
Ben-Josef Edgar, Taylor Jeremy M G, Lawrence Theodore S: Radiotherapy improves survival in unresectable pancreatic cancer: small trial but big (and credible) results. Journal of clinical oncology 30(13): 1565-6; author reply 1566-7, May 2012.